Several studies have reported that serpina1, serpina2, and serpina3 are associated with COPD [5,6], Serpina3-encoded AACT is a plasma protease inhibitor that targets neutrophil cathepsin G and elastase [7,8]. Here, SERPINA1 is linked to chronic obstructive pulmonary disease.